These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 32034563)
1. The influence of photodynamic therapy on the Warburg effect in esophageal cancer cells. Gan J; Li S; Meng Y; Liao Y; Jiang M; Qi L; Li Y; Bai Y Lasers Med Sci; 2020 Oct; 35(8):1741-1750. PubMed ID: 32034563 [TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2. Li S; Huang P; Gan J; Ling X; Du X; Liao Y; Li L; Meng Y; Li Y; Bai Y Eur J Pharmacol; 2019 Jul; 854():232-239. PubMed ID: 31004604 [TBL] [Abstract][Full Text] [Related]
3. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway. Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097 [TBL] [Abstract][Full Text] [Related]
4. Depletion of PKM2 leads to impaired glycolysis and cell death in 2-demethoxy-2,3-ethylenediamino hypocrellin B-photoinduced A549 cells. Zhou Z; Liu Y; Qin M; Sheng W; Wang X; Li Z; Zhong R J Photochem Photobiol B; 2014 May; 134():1-8. PubMed ID: 24792468 [TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin enhances the anti-tumour effect of photodynamic therapy by targeting PKM2-mediated glycolysis in oesophageal cancer cell. Jin M; Shi L; Wang L; Zhang D; Li Y J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2296695. PubMed ID: 38111311 [TBL] [Abstract][Full Text] [Related]
6. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma. Li C; Zhao Z; Zhou Z; Liu R Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118 [TBL] [Abstract][Full Text] [Related]
7. The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma. Xiaoyu H; Yiru Y; Shuisheng S; Keyan C; Zixing Y; Shanglin C; Yuan W; Dongming C; Wangliang Z; Xudong B; Jie M Technol Cancer Res Treat; 2018 Jan; 17():1533033818780063. PubMed ID: 29916308 [TBL] [Abstract][Full Text] [Related]
8. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells. Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386 [TBL] [Abstract][Full Text] [Related]
9. Vacuolar H Son SW; Chau GC; Kim ST; Um SH Cells; 2019 Sep; 8(10):. PubMed ID: 31554233 [TBL] [Abstract][Full Text] [Related]
10. Suppressed "Warburg Effect" in Nasopharyngeal Carcinoma Via the Inhibition of Pyruvate Kinase Type M2-Mediated Energy Generation Pathway. Zhao P; Zhou M; Chen R; Su R Technol Cancer Res Treat; 2020; 19():1533033820945804. PubMed ID: 32815467 [TBL] [Abstract][Full Text] [Related]
11. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis. Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609 [TBL] [Abstract][Full Text] [Related]
12. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [ Patel CB; Beinat C; Xie Y; Chang E; Gambhir SS Neoplasia; 2021 Jan; 23(1):58-67. PubMed ID: 33221711 [TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species. Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis. Li L; Song D; Qi L; Jiang M; Wu Y; Gan J; Cao K; Li Y; Bai Y; Zheng T Cancer Lett; 2021 Nov; 520():143-159. PubMed ID: 34256094 [TBL] [Abstract][Full Text] [Related]
15. STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/β-catenin pathway in cervical carcinoma cells. Li R; Li P; Wang J; Liu J Life Sci; 2020 Oct; 258():118190. PubMed ID: 32777299 [TBL] [Abstract][Full Text] [Related]
16. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells. Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782 [TBL] [Abstract][Full Text] [Related]
17. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose. Li X; Deng S; Liu M; Jin Y; Zhu S; Deng S; Chen J; He C; Qin Q; Wang C; Zhao G Cell Death Dis; 2018 Jan; 9(2):133. PubMed ID: 29374159 [TBL] [Abstract][Full Text] [Related]
18. Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway. Yang Y; Li S; Shi W; Jin G; Guo D; Li A; Wang B; Lu B; Feng S Int Immunopharmacol; 2024 Dec; 142(Pt B):113247. PubMed ID: 39321706 [TBL] [Abstract][Full Text] [Related]
19. Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cells. Jung Y; Jang YJ; Kang MH; Park YS; Oh SJ; Lee DC; Xie Z; Yoo HS; Park KC; Yeom YI Mol Cells; 2013 Apr; 35(4):335-41. PubMed ID: 23515579 [TBL] [Abstract][Full Text] [Related]
20. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells. Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]